Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method Shima ShabaniMehdi Forouzandeh MoghadamSeyed Latif Mousavi Gargari Original Paper 14 August 2021 Article: 115
Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer Johann EbadfardzadehMandana KazemiRoghayeh Sheervalilou Original Paper 14 August 2021 Article: 114
Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy Ebru GüçlüCanan Eroğlu GüneşHasibe Vural Original Paper 11 August 2021 Article: 113
Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line Ertan KanburAhmet Tarık BaykalAzmi Yerlikaya Original Paper 07 August 2021 Article: 112
Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis Shuxian ZhangJiale DuanYalan Wang Original Paper 06 August 2021 Article: 111
Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis M. S. SintoShaji ThomasS. Kannan Original Paper 06 August 2021 Article: 110
Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway Yeliz EkiciAbdullah YilmazFeyza Nur Tuncer Original Paper 06 August 2021 Article: 109
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial Eman GhonaimSahar El-HaggarSuzy Gohar Original Paper 06 August 2021 Article: 108
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue? Riccardo Ray ColciagoAnna CavalloMaria Carmen De Santis Original Paper 03 August 2021 Article: 107
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions Holly MaulhardtAlyson MarinGere diZerega Original Paper Open access 31 July 2021 Article: 106
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro Richard C. ZierenLiang DongSarah R. Amend Original Paper Open access 31 July 2021 Article: 105
Correction to: SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway Jin LiYiming LaiZhenghui Guo Correction 31 July 2021 Article: 104
MPI-based bioinformatic analysis and co-inhibitory therapy with mannose for oral squamous cell carcinoma Yufei YaoWei LiuKun Wang Original Paper 27 July 2021 Article: 103
Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia Shirin FerdowsiSeyed H. GhaffariSaeed Mohammadi Original Paper 27 July 2021 Article: 102
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? Saptarshi SinhaChanakya Nath Kundu Review Article 24 July 2021 Article: 101
Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation Valquíria Mariane Oliveira PóvoaJeany DelafioriRodrigo Ramos Catharino Original Paper 24 July 2021 Article: 100
Correction to: Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells Zhenghui GuoHai HuangJian Huang Correction 24 July 2021 Article: 99
Phase II study of neoadjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer clinical T4 or N2-3 Akiko SerizawaHidekazu KuramochiMasakazu Yamamoto Original Paper 24 July 2021 Article: 98
